Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
230 participants
INTERVENTIONAL
2011-08-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The present study will evaluate the effect of encouraging patients to put their eyedrops using one of 2 techniques, randomly assigned, to determine which is more successful at instilling the eye drop into the eye while spending the least amount of drug.
In one of the techniques the patient instills the eye drop with their eyes open in the inferior cul de sac. In the other technique the patient instills the eye drop with the eyes closed near the inner canthal region.
Patients will be randomized to encouragement to use the drops with either of the techniques. Encouragement will take place over a visit where they will be subjected to:
* Baseline evaluation of eye drop instillation using their usual technique.
* Short (2-5 minute) educational session session for the assigned technique.
* Followup evaluation immediately after the educational session.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of "Eye Drop Guide" on the Success Rate of Eye Drops Self-instillation in Glaucoma Patients
NCT01704248
Glaucoma Eye Drop Instillation: Impact of Education
NCT01416415
Compliance and Administration Technique in Topical Drug Therapy of Glaucoma
NCT00303121
An App-based Instructional Platform to Improve Eye Drop Recall
NCT06045390
Combined Phacoemulsification and Diode Laser Therapy in Chronic Angle Closure Glaucoma
NCT05576493
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Open-eyes
Patients in this arm are encourage to attempt eye drop instillation using the most commonly used technique that involves looking up, pulling inferior lid down and putting the drop in the inferior cul de sac.
Encouragement to attempt eye drop instillation with a specific technique
Encouragement to one of the 2 techniques (open eyes and closed eyes) is accomplished through a standardized educational session designed to take2-5 minutes.
Closed-eyes
Patients in this group are encouraged to attempt eye drop instillation with both eyes closed near the medial canthal region. After feeling contact with the drop on the skin the drop is expected to enter the eye when opening the eye and resuming blinking.
Encouragement to attempt eye drop instillation with a specific technique
Encouragement to one of the 2 techniques (open eyes and closed eyes) is accomplished through a standardized educational session designed to take2-5 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Encouragement to attempt eye drop instillation with a specific technique
Encouragement to one of the 2 techniques (open eyes and closed eyes) is accomplished through a standardized educational session designed to take2-5 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Use of topical glaucoma medication in both eyes for at least 1 year prior to enrollment
* VA of 20/60 or better with habitual correction in at least one eye
Exclusion Criteria
* Received topical anesthesia for IOP measurement or other reason within the last 2 hours.
* Rejects participation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oftalmologia Hospital Sotero del Rio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
1 Pontificia Universidad Catolica de Chile, 2 Hospital Sotero del Rio.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eugenio A Maul, MD MPH
Role: PRINCIPAL_INVESTIGATOR
Pontificia Universidad Catolica de Chile. Hospital Sotero del Rio.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Sotero del Rio
Santiago, RM, Chile
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Oftalmo_Glaucoma_001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.